Svar Life Science (Radioimmunoassay and Chromogranin A Neolisa) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Svar Life Science (Radioimmunoassay and Chromogranin A Neolisa) General Information

Description

A portfolio of bio-pharmaceutical product line. The portfolio comprises of an immunoassay that uses radiolabeled molecules in a step-wise formation of immune complexes.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Drug Discovery
Acquirer
Primary Office
  • P.O. Box 50117
  • 202 11 Malmo
  • Sweden
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Svar Life Science (Radioimmunoassay and Chromogranin A Neolisa) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Svar Life Science (Radioimmunoassay and Chromogranin A Neolisa)‘s full profile, request access.

Request a free trial

Svar Life Science (Radioimmunoassay and Chromogranin A Neolisa) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Svar Life Science (Radioimmunoassay and Chromogranin A Neolisa)‘s full profile, request access.

Request a free trial